Endothelial antioxidant actions of dihydropyridines and angiotensin converting enzyme inhibitors (original) (raw)
Antioxidant and Nitric Oxide-Sparing Actions of Dihydropyridines and ACE Inhibitors Differ in Human Endothelial Cells
Anke Fender
Pharmacology, 2006
View PDFchevron_right
Comparison of inhibitors of superoxide generation in vascular smooth muscle cells
Chris Wilcox
British Journal of Pharmacology, 2009
View PDFchevron_right
Synergistic Antihypertensive Effects of Nifedipine on Endothelium : Concurrent Release of NO and Scavenging of Superoxide
Leszek Kalinowski
Hypertension, 2001
View PDFchevron_right
3′,4′-Dihydroxyflavonol Reduces Superoxide and Improves Nitric Oxide Function in Diabetic Rat Mesenteric Arteries
Chen-Huei Leo, Owen Woodman
PLoS ONE, 2011
View PDFchevron_right
Nitrosonifedipine Ameliorates the Progression of Type 2 Diabetic Nephropathy by Exerting Antioxidative Effects
Shoji Kagami
PLoS ONE, 2014
View PDFchevron_right
Protective effects of sulfhydryl-containing angiotensin converting enzyme inhibitors against free radical injury in endothelial cells
William Weglicki
Biochemical Pharmacology, 1990
View PDFchevron_right
Vascular Oxidative Stress: Pharmacological and Nonpharmacological Approaches
Valeria CONTI
Oxidative Medicine and Cellular Longevity, 2018
View PDFchevron_right
Acute inhibition of superoxide formation and Rac1 activation by nitric oxide and iloprost in human vascular smooth muscle cells in response to the thromboxane A2 analogue, U46619
Andrew Newby, Saima Muzaffar
Prostaglandins, leukotrienes, and essential fatty acids
View PDFchevron_right
Angiotensin-(1-7)-Stimulated Nitric Oxide and Superoxide Release From Endothelial Cells
T. Malinski
Hypertension, 2001
View PDFchevron_right
Influence of pyridoxylidene aminoguanidine on biomarkers of the oxidative stress and selected metabolic parameters of rats with diabetes mellitus
Zuzana Orszaghova, Jana Muchová
General Physiology and Biophysics, 2009
View PDFchevron_right
Nitric oxide, a possible mediator of 1,4-dihydropyridine-induced photorelaxation of vascular smooth muscle
detlef bieger
British Journal of Pharmacology, 1996
View PDFchevron_right
Improvement of Nitric Oxide–Dependent Vasodilatation by HMG-CoA Reductase Inhibitors Through Attenuation of Endothelial Superoxide Anion Formation
Ingo Just
Arteriosclerosis, Thrombosis, and Vascular Biology, 2000
View PDFchevron_right
Sulfhydryl angiotensin-converting enzyme inhibition induces sustained reduction of systemic oxidative stress and improves the nitric oxide pathway in patients with essential hypertension
Vincenzo Sica
American Heart Journal, 2004
View PDFchevron_right
Diabetes and Vascular Disease: Basic Concepts of Nitric Oxide Physiology, Endothelial Dysfunction, Oxidative Stress and Therapeutic Possibilities
Verena Capellini
Current Vascular Pharmacology, 2010
View PDFchevron_right
New 1,4-Dihydropyridines Down-regulate Nitric Oxide in Animals with Streptozotocin-induced Diabetes Mellitus and Protect Deoxyribonucleic Acid against Peroxynitrite Action
Nikolajs Sjakste
Basic & Clinical Pharmacology & Toxicology, 2016
View PDFchevron_right
Targeting Oxidant Stress as a Strategy for Preventing Vascular Complications of Diabetes and Metabolic Syndrome
Toyoshi Inoguchi
Nutraceuticals, Glycemic Health and …, 2008
View PDFchevron_right
Angiotensin II-induced superoxide anion generation in human vascular endothelial cells Role of membrane-bound NADH-/NADPH-oxidases
Christoph Garlichs
Cardiovascular Research, 1999
View PDFchevron_right
Nitric oxide suppresses NADPH oxidase-dependent superoxide production by S-nitrosylation in human endothelial cells
Gregory Dusting
Cardiovascular Research, 2007
View PDFchevron_right
Vascular NADH Oxidase Is Involved in Impaired Endothelium-Dependent Vasodilation in OLETF Rats, a Model of Type 2 Diabetes
Chi Kim
Diabetes, 2002
View PDFchevron_right
Vascular protective effects of dihydropyridine calcium antagonists. Involvement of endothelial nitric oxide
Anke Fender
Pharmacology, 2003
View PDFchevron_right
Angiotensin antagonist drugs as and #8220;source antioxidants and #8221; and #8211; down-regulation of NADPH oxidase activation mediates many of their protective benefits, independent of hypertension control
Charles Glassman
Oxidants and Antioxidants in Medical Science, 2015
View PDFchevron_right
Modulation of antioxidative response in the therapy of hypertension and other cardiovascular diseases
Ima Dovinova
Neuro endocrinology letters
View PDFchevron_right
The efficacy of newly synthesised agent and natural antioxidant treatment in diabetic and hypertensive rats
stanislava jankyova
View PDFchevron_right
Pharmacological induction of vascular extracellular superoxide dismutase expression in vivo
Vera Balz
Journal of Cellular and Molecular Medicine, 2009
View PDFchevron_right
Modulation of renal superoxide dismutase by telmisartan therapy in C57BL/6-Ins2Akita diabetic mice
Takamune Takahashi
Hypertension Research, 2012
View PDFchevron_right